Cargando…
Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
BACKGROUND: There is a close relationship between cirrhosis and hepatocellular carcinoma (HCC). Transjugular intrahepatic portosystemic shunt (TIPS) has good clinical effect in treating the complication of portal hypertension. However, because of the risk of postoperative liver failure, severe compl...
Autores principales: | Luo, Shi-Hua, Chu, Jian-Guo, Huang, He, Yao, Ke-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658383/ https://www.ncbi.nlm.nih.gov/pubmed/31367619 http://dx.doi.org/10.12998/wjcc.v7.i13.1599 |
Ejemplares similares
-
Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt
por: Luo, Shi-Hua, et al.
Publicado: (2017) -
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
por: Luo, Shi-Hua, et al.
Publicado: (2019) -
Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications
por: Luo, Shi-Hua, et al.
Publicado: (2023) -
Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
por: Dong, Fang, et al.
Publicado: (2019) -
Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision
por: Duong, Nikki, et al.
Publicado: (2022)